Frank has mentioned numerous times the possibility of partnering with a device manufacturer to produce the scaffold, gel, etc... I believe the company is pushing the scaffold first, because it will be easiest to pass the FDA criteria in order to market, thus providing funding for future products. He has also mentioned NVIV is an acquisition target, but I'm pretty sure they would pursue partnerships first based on what he has said in presentations.
Frank has mentioned numerous times the possibility of partnering with a device manufacturer to produce the products. I believe NVIV plans to do so with the scaffold once FDA gives approval in order to generate funding for the next product in the pipeline.
I thought this entire year was dedicated to the installation of 3-D printers and the other day someone said that they were printing but not in 3-D??? Why would they not want to keep their manufacturing right there at home??? With the advances being made at the moment with stem cells and scaffolds (a nose, a trachea, ect) I can see where INVIVO is in a position to advance their scaffold research to the clear blue sky. They are saying it takes only 3-weeks to create an ear or a nose in the lab using stem cells and scaffolds. Langer is right in the mix with this new facility. What say you???